Home / Health / New Heart Guidelines: Start Cholesterol Care Early
New Heart Guidelines: Start Cholesterol Care Early
4 Apr
Summary
- New guidelines emphasize early cholesterol management for heart disease prevention.
- The PREVENT calculator replaces old tools for better risk assessment.
- Specific LDL targets are now set based on risk categories.

Updated guidelines from the American College of Cardiology and American Heart Association now prioritize early intervention for cholesterol management to prevent heart disease. These recommendations emphasize initiating cholesterol care at younger ages and utilize the new PREVENT calculator for more accurate 10- and 30-year risk assessments. Specific LDL cholesterol targets, such as under 100, 70, or 55 mg/dL, are established based on a person's risk category.
The PREVENT calculator replaces previous risk assessment tools, incorporating recent data to predict atherosclerotic cardiovascular disease (ASCVD) risk more effectively for adults aged 30-79. Coronary artery calcium scans and Lp(a) testing are also highlighted for refined risk evaluation, especially in borderline cases.
Specific LDL targets have been reintroduced, with goals tailored to risk levels. For primary prevention, targets include under 100 mg/dL for borderline/intermediate risk and under 70 mg/dL for high risk. Secondary prevention for very high-risk individuals aims for LDL under 55 mg/dL.
Screening for high cholesterol is now recommended for children aged 9-11, with earlier assessment advised for those with risk factors. This focus on early screening aims to reduce cumulative lipid damage over a lifetime. Lifestyle changes, including diet, exercise, and weight management, are fundamental. Statins remain the primary medication, with other drugs available if goals are not met.
Monitoring of lipids is crucial, with reassessments typically occurring 4-12 weeks after therapy initiation. The guidelines also provide specific recommendations for individuals with diabetes, kidney disease, and South Asian ancestry, acknowledging their increased cardiovascular risk. The overall aim is to significantly reduce ASCVD deaths by acting proactively.